BACITRACIN ZINC AND POLYMYXIN B SULFATE Drug Patent Profile
Which patents cover Bacitracin Zinc And Polymyxin B Sulfate, and what generic alternatives are available?
Bacitracin Zinc And Polymyxin B Sulfate is a drug marketed by Bausch And Lomb Inc, Padagis Us, and Sciegen Pharms. and is included in three NDAs.
The generic ingredient in BACITRACIN ZINC AND POLYMYXIN B SULFATE is bacitracin zinc; polymyxin b sulfate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bacitracin Zinc And Polymyxin B Sulfate
A generic version of BACITRACIN ZINC AND POLYMYXIN B SULFATE was approved as bacitracin zinc; polymyxin b sulfate by BAUSCH AND LOMB INC on January 26th, 1995.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
- What are the global sales for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
- What is Average Wholesale Price for BACITRACIN ZINC AND POLYMYXIN B SULFATE?
Summary for BACITRACIN ZINC AND POLYMYXIN B SULFATE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | BACITRACIN ZINC AND POLYMYXIN B SULFATE at DailyMed |
Recent Clinical Trials for BACITRACIN ZINC AND POLYMYXIN B SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Glaxo Wellcome | N/A |
See all BACITRACIN ZINC AND POLYMYXIN B SULFATE clinical trials
Pharmacology for BACITRACIN ZINC AND POLYMYXIN B SULFATE
| Drug Class | Polymyxin-class Antibacterial |
| Physiological Effect | Decreased Cell Wall Synthesis & Repair |
US Patents and Regulatory Information for BACITRACIN ZINC AND POLYMYXIN B SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064046-001 | Jan 26, 1995 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Padagis Us | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 065022-001 | Feb 27, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sciegen Pharms | BACITRACIN ZINC AND POLYMYXIN B SULFATE | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 064028-001 | Jan 30, 1995 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
